Agilent (A) Revenue & Revenue Breakdown
Agilent Revenue Highlights
Latest Revenue (Y)
$6.83B
Latest Revenue (Q)
$1.58B
Main Segment (Y)
Non-Instrumentation and Other
Main Geography (Y)
Americas
Agilent Revenue by Period
Agilent Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-10-31 | $6.83B | -0.22% |
2022-10-31 | $6.85B | 8.37% |
2021-10-31 | $6.32B | 18.36% |
2020-10-31 | $5.34B | 3.41% |
2019-10-31 | $5.16B | 5.07% |
2018-10-31 | $4.91B | 9.88% |
2017-10-31 | $4.47B | 6.43% |
2016-10-31 | $4.20B | 4.06% |
2015-10-31 | $4.04B | -42.16% |
2014-10-31 | $6.98B | 2.93% |
2013-10-31 | $6.78B | -1.11% |
2012-10-31 | $6.86B | 3.67% |
2011-10-31 | $6.62B | 21.51% |
2010-10-31 | $5.44B | 21.49% |
2009-10-31 | $4.48B | -22.39% |
2008-10-31 | $5.77B | 6.53% |
2007-10-31 | $5.42B | 8.99% |
2006-10-31 | $4.97B | -3.23% |
2005-10-31 | $5.14B | -28.44% |
2004-10-31 | $7.18B | 18.58% |
2003-10-31 | $6.06B | 0.77% |
2002-10-31 | $6.01B | -28.42% |
2001-10-31 | $8.40B | -22.06% |
2000-10-31 | $10.77B | 29.31% |
1999-10-31 | $8.33B | 4.77% |
1998-10-31 | $7.95B | - |
Agilent Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-07-31 | $1.58B | 0.32% |
2024-04-30 | $1.57B | -5.13% |
2024-01-31 | $1.66B | -1.78% |
2023-10-31 | $1.69B | 0.96% |
2023-07-31 | $1.67B | -2.62% |
2023-04-30 | $1.72B | -2.22% |
2023-01-31 | $1.76B | -5.03% |
2022-10-31 | $1.85B | 7.63% |
2022-07-31 | $1.72B | 6.91% |
2022-04-30 | $1.61B | -4.00% |
2022-01-31 | $1.67B | 0.84% |
2021-10-31 | $1.66B | 4.67% |
2021-07-31 | $1.59B | 4.00% |
2021-04-30 | $1.52B | -1.49% |
2021-01-31 | $1.55B | 4.38% |
2020-10-31 | $1.48B | 17.61% |
2020-07-31 | $1.26B | 1.86% |
2020-04-30 | $1.24B | -8.77% |
2020-01-31 | $1.36B | -0.73% |
2019-10-31 | $1.37B | 7.30% |
2019-07-31 | $1.27B | 2.91% |
2019-04-30 | $1.24B | -3.58% |
2019-01-31 | $1.28B | -0.77% |
2018-10-31 | $1.29B | 7.56% |
2018-07-31 | $1.20B | -0.25% |
2018-04-30 | $1.21B | -0.41% |
2018-01-31 | $1.21B | 1.85% |
2017-10-31 | $1.19B | 6.73% |
2017-07-31 | $1.11B | 1.09% |
2017-04-30 | $1.10B | 3.28% |
2017-01-31 | $1.07B | -3.96% |
2016-10-31 | $1.11B | 6.42% |
2016-07-31 | $1.04B | 2.45% |
2016-04-30 | $1.02B | -0.88% |
2016-01-31 | $1.03B | -0.68% |
2015-10-31 | $1.03B | 2.07% |
2015-07-31 | $1.01B | 5.30% |
2015-04-30 | $963.00M | -6.14% |
2015-01-31 | $1.03B | -43.16% |
2014-10-31 | $1.80B | 2.21% |
2014-07-31 | $1.77B | 2.02% |
2014-04-30 | $1.73B | 3.10% |
2014-01-31 | $1.68B | -2.27% |
2013-10-31 | $1.72B | 4.00% |
2013-07-31 | $1.65B | -4.62% |
2013-04-30 | $1.73B | 3.10% |
2013-01-31 | $1.68B | -4.92% |
2012-10-31 | $1.77B | 2.55% |
2012-07-31 | $1.72B | -0.58% |
2012-04-30 | $1.73B | 5.99% |
2012-01-31 | $1.64B | -5.38% |
2011-10-31 | $1.73B | 2.19% |
2011-07-31 | $1.69B | 0.83% |
2011-04-30 | $1.68B | 10.40% |
2011-01-31 | $1.52B | -3.62% |
2010-10-31 | $1.58B | 13.87% |
2010-07-31 | $1.38B | 8.89% |
2010-04-30 | $1.27B | 4.78% |
2010-01-31 | $1.21B | 3.94% |
2009-10-31 | $1.17B | 10.41% |
2009-07-31 | $1.06B | -3.12% |
2009-04-30 | $1.09B | -6.43% |
2009-01-31 | $1.17B | -21.27% |
2008-10-31 | $1.48B | 2.56% |
2008-07-31 | $1.44B | -0.82% |
2008-04-30 | $1.46B | 4.52% |
2008-01-31 | $1.39B | - |
Agilent Revenue Breakdown
Agilent Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Oct 23 | Oct 22 | Oct 21 | Oct 20 | Oct 19 |
---|---|---|---|---|---|
Non-Instrumentation and Other | $4.09B | $3.94B | $3.66B | $3.09B | $3.01B |
Diagnostics and Genomics | $1.41B | - | - | - | - |
Life Sciences and Applied Markets | $3.86B | - | - | - | - |
Agilent CrossLab | $1.57B | - | - | - | - |
Instrumentation | $2.74B | $2.91B | $2.66B | $2.25B | $2.15B |
Latest
Quarterly Revenue by Product
Product/Service | Jul 24 | Apr 24 | Jan 24 | Oct 23 | Jul 23 | Jan 23 | Oct 22 | Jul 22 | Apr 22 | Jan 22 | Oct 21 | Jul 21 | Apr 21 | Jan 21 | Oct 20 | Jul 20 | Apr 20 | Jan 20 | Oct 19 | Jul 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Life Sciences and Applied Markets | $782.00M | $754.00M | $846.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Diagnostics and Genomics | $385.00M | $417.00M | $407.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Agilent CrossLab | $411.00M | $402.00M | $405.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Non-Instrumentation and Other | - | - | $1.03B | $1.04B | $1.03B | $997.00M | $1.02B | $981.00M | $961.00M | $983.00M | $956.00M | $946.00M | $893.00M | $867.00M | $844.00M | $735.00M | $747.00M | $764.00M | $780.00M | $769.00M |
Instrumentation | - | - | $630.00M | $651.00M | $643.00M | $759.00M | $833.00M | $737.00M | $646.00M | $691.00M | $704.00M | $640.00M | $632.00M | $681.00M | $639.00M | $526.00M | $491.00M | $593.00M | $587.00M | $505.00M |
Latest
Agilent Revenue Breakdown by Country
Annual Revenue by Country
Country | Oct 23 | Oct 22 | Oct 21 | Oct 20 | Oct 19 |
---|---|---|---|---|---|
Europe | $1.75B | - | - | - | - |
Americas | $2.73B | - | - | - | - |
Asia Pacific | $2.35B | - | - | - | - |
CHINA | - | $1.50B | $1.27B | $1.09B | $1.02B |
UNITED STATES | - | $2.38B | $2.16B | $1.75B | $1.62B |
Rest Of World | - | $2.96B | $2.89B | $2.50B | $2.52B |
Latest
Quarterly Revenue by Country
Country | Jul 24 | Apr 24 | Jan 24 | Oct 23 | Jul 23 | Jan 23 | Oct 22 | Jul 22 | Apr 22 | Jan 22 | Oct 21 | Jul 21 | Apr 21 | Jan 21 | Oct 20 | Jul 20 | Apr 20 | Jan 20 | Oct 19 | Jul 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Europe | $432.00M | $426.00M | $458.00M | $889.00M | $432.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Americas | $626.00M | $637.00M | $630.00M | $1.39B | $667.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Asia Pacific | $520.00M | $510.00M | $570.00M | $1.17B | $573.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Non-Instrumentation and Other | - | - | - | - | - | $997.00M | $1.02B | $981.00M | $961.00M | $983.00M | $956.00M | $946.00M | $893.00M | $867.00M | $844.00M | $735.00M | $747.00M | $764.00M | $780.00M | $769.00M |
Instrumentation | - | - | - | - | - | $759.00M | $833.00M | $737.00M | $646.00M | $691.00M | $704.00M | $640.00M | $632.00M | $681.00M | $639.00M | $526.00M | $491.00M | $593.00M | $587.00M | $505.00M |
Latest
Agilent Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
TMO | Thermo Fisher Scientific | $42.86B | $10.60B |
DHR | Danaher | $14.03B | $3.40B |
A | Agilent | $6.83B | $1.58B |
ILMN | Illumina | $4.50B | $1.08B |
CRL | Charles River Laboratories | $4.13B | $1.03B |
MTD | Mettler-Toledo | $3.79B | $954.53M |
IDXX | IDEXX Laboratories | $3.66B | $975.54M |
WAT | Waters | $2.96B | $740.30M |
RVTY | Revvity | $2.75B | $641.72M |
GH | Guardant Health | $563.95M | $177.24M |